For the Inventor, By the Inventor

Enter assignee name

Navigo Proteins Gmbh

USPTO Granted Patents = 14

CIPO Patents = 1

EPO Patents = 19

Trademarks = 3

Forward Citations = 12

Loading Chart...

Loading Chart...

17 inventors (with patents filed for the assignee):

Erik Fiedler (13 out of 23 patents)

Ulrich Haupts (10 out of 15 patents)

Mathias Kahl (4 out of 4 patents)

4. Eva Bosse-Doenecke (3 out of 4 patents)

5. Maren Meysing (3 out of 4 patents)

6. Hanna Bobolowski (3 out of 3 patents)

7. Anja Katzschmann (2 out of 2 patents)

8. Paul Knick (2 out of 3 patents)

9. Madlen Zwarg (2 out of 2 patents)

10. Jonathan Lotze (2 out of 2 patents)

11. Eva Bosse-Doenecke (2 out of 2 patents)

12. Manja Gloser (1 out of 2 patents)

13. Florian Settele (1 out of 1 patent)

14. Markus Liebscher (1 out of 1 patent)

15. Manja Gloser-Bräunig (1 out of 1 patent)

14 patents: Sort by Forward Citations

1. 12754184 - BINDING PROTEIN SPECIFIC FOR THE SPIKE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2) (2026-10-06),

2. 12577276 - IMMUNOGLOBULIN BINDING PROTEINS FOR AFFINITY PURIFICATION (2026-03-17),

3. 12570690 - IMMUNOGLOBULIN BINDING PROTEINS FOR AFFINITY PURIFICATION (2026-03-10),

4. 12552832 - IMMUNOGLOBULIN BINDING POLYPEPTIDES (2026-02-17),

5. 12509493 - NOVEL FOLR1 SPECIFIC BINDING PROTEINS FOR CANCER DIAGNOSIS AND TREATMENT (2025-12-30),

6. 12466857 - NOVEL TRIPLE-HELICAL POLYPEPTIDES LACKING BINDING AFFINITY FOR THE FC DOMAIN OF IMMUNOGLOBULIN AND USES THEREOF (2025-11-11),

7. 12286458 - Binding proteins for the enzyme acid alpha glucosidase (GAA) and uses thereof (2025-04-29),

8. 11813336 - Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker (2023-11-14),

9. 11414466 - Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer (2022-08-16),

10. 11230576 - Alkaline stable immunoglobulin-binding proteins (2022-01-25),

11. 11208436 - Populations of polypeptides having a triple-helical structure (2021-12-28),

12. 10858405 - EGFR binding proteins (2020-12-08),

13. 10808042 - Immunoglobulin-binding proteins and their use in affinity purification (2020-10-20),

14. 10584152 - Binding proteins based on di-ubiquitin muteins and methods for generation (2020-03-10),

Navigo Proteins GmbH, based in Halle, Germany, specializes in the development and production of innovative protein-based solutions for various applications in the life sciences sector. The company focuses on advanced protein engineering and offers services that include the design and optimization of proteins for therapeutic and diagnostic purposes. With a commitment to enhancing biopharmaceutical development, Navigo Proteins leverages cutting-edge technologies to address complex challenges in drug discovery and development.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#3 in Halle

#2,906 in Germany

#42,199 in the World

Navigo Proteins Gmbh

Forward Citations = 12

17 inventors:

Erik Fiedler (13 out of 23 patents)

Ulrich Haupts (10 out of 15 patents)

Mathias Kahl (4 out of 4 patents)

4. Eva Bosse-Doenecke (3 out of 4 patents)

5. Maren Meysing (3 out of 4 patents)

Please report any incorrect information to [email protected]

Loading…